Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Insights Imaging ; 15(1): 122, 2024 May 20.
Article in English | MEDLINE | ID: mdl-38767729

ABSTRACT

Pulmonary embolism (PE) is a significant contributor to global cardiovascular-related mortality that mainly depends on the severity of the event. The treatment approach for intermediate and high-risk PE remains a topic of debate due to the fine balance between hemodynamic deterioration and bleeding risk. The initial treatment choice for intermediate-risk PE with hemodynamic deterioration and high-risk PE is historically systemic thrombolysis, but this approach is not always effective and carries a notable risk of severe bleeding. For such patients, various interventional treatments have been introduced to clinical practice, including catheter-directed lysis (CDL), ultrasound-assisted CDL, pharmacomechanical CDL, and aspiration thrombectomy. However, the optimal treatment approach remains uncertain. Encouraging outcomes have been presented assessing the novel endovascular treatments, in terms of reducing right ventricular dysfunction and improving hemodynamic stability, opening the possibility of using these devices to prevent hemodynamic instability in less severe cases. However, ongoing randomized trials that assess the efficacy and the association with mortality, especially for aspiration devices, have not yet published their final results. This article aims to offer a comprehensive update of the available catheter-directed therapies for PE, with a focus on novel mechanical thrombectomy techniques, assessing their safety and efficacy, after comparison to the conventional treatment. CRITICAL RELEVANCE STATEMENT: This is a comprehensive review of the indications of use, techniques, and clinical outcomes of the most novel endovascular devices for the treatment of pulmonary embolism. KEY POINTS: Mechanical thrombectomy is an effective tool for patients with PE. Aspiration devices prevent hemodynamic deterioration. Catheter directed therapy reduces bleeding complications.

2.
Radiol Med ; 129(4): 566-574, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38512617

ABSTRACT

PURPOSE: We aimed to compare the diagnostic yield and procedure-related complications of two different types of systems for percutaneous CT-guided lung biopsy. MATERIAL AND METHODS: All patients with a lung lesion who underwent a CT-guided lung biopsy at our institution, between January 2019 and 2021, were retrospectively analyzed. The inclusion criteria were: (a) Procedures performed using either a fully automated tru-cut or a semi-automated full-core biopsy needle, (b) CT images demonstrating the position of the needles within the lesion, (c) histopathological result of the biopsy and (d) clinical follow-up for at least 12 months and\or surgical histopathological results. A total of 400 biopsy fulfilling the inclusion criteria were selected and enrolled in the study. RESULTS: Overall technical success was 100% and diagnostic accuracy was 84%. Tru-cut needles showed a significantly higher diagnostic accuracy when compared to full-core needles (91% vs. 77%, p = 0.0004) and a lower rate of pneumothorax (31% vs. 41%, p = 0.047). Due to the statistically significant different of nodules size between the two groups, we reiterated the statistical analysis splitting our population around the 20 mm cut-off for nodule size. We still observed a significant difference in diagnostic accuracy between tru-cut and full-core needles favoring the former for both smaller and larger lesions (81% vs. 71%, p = 0.025; and 92% vs. 81%; p = 0.01, respectively). CONCLUSION: Our results demonstrated that the use of automated tru-cut needles is associated with higher histopathological diagnostic accuracy compared to semi-automated full-core needles for CTLB.


Subject(s)
Lung Neoplasms , Humans , Retrospective Studies , Lung Neoplasms/pathology , Lung/diagnostic imaging , Lung/pathology , Image-Guided Biopsy , Tomography, X-Ray Computed
3.
Br J Radiol ; 95(1130): 20210434, 2022 Feb 01.
Article in English | MEDLINE | ID: mdl-34808070

ABSTRACT

OBJECTIVES: To investigate whether lesion imaging features may condition the outcome of CT-guided lung biopsy (CTLB) and to develop a scoring system of biopsy outcome prediction. METHODS: This is a single center retrospective study on 319 CTLBs that were performed in 319 patients (167 males/152 females, mean age 68 ± 12.2). Uni- and multivariate analysis were performed aiming to assess the imaging features that are likely to be correlated to a negative biopsy outcome and patients were stratified in groups accordingly. RESULTS: Technical success was 100%. 78% of the biopsies (250/319) led to a concrete histology report (218 malignant/32 benign). The remaining lesions led to concrete histology at a second attempt that occurred on a later time. Multivariate analysis revealed increased risk of inconclusive result for nodules with low fludeoxyglucose uptake [odds ration (OR) = 2.64, 95% confidence interval (CI) 1.4-4.97; p = 0.003], for nodules with diameter smaller than 18 mm (OR = 2.03, 95% CI 1.14-3.62; p = 0.017) and for nodules that are located in one of the lung bases (OR = 1.96, 95% CI 1.06-3.62; p = 0.033). Three different groups of patients were identified accordingly with low (<30%), medium (30-50%) and high (>50%) probability of obtaining an inconclusive biopsy sample. CONCLUSION: This study confirms that percutaneous CT-guided biopsy in nodules that are either small in diameter or present low positron emission tomography-fludeoxyglucose uptake or are in one of the lung bases may lead to inconclusive histology. This information should be factored when planning percutaneous biopsies of such nodules in terms of patient informed consent and biopsy strategy. ADVANCES IN KNOWLEDGE: Inconclusive histology after lung biopsy may be subject to factors irrelevant to technical success. Lung biopsy histology outcomes may be predicted and avoided after adequate planning.


Subject(s)
Image-Guided Biopsy/methods , Lung Neoplasms/pathology , Lung/pathology , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Analysis of Variance , Female , Fluorodeoxyglucose F18/pharmacokinetics , Humans , Lung/metabolism , Lung Neoplasms/metabolism , Male , Middle Aged , Positron-Emission Tomography , Radiopharmaceuticals/pharmacokinetics , Retrospective Studies
4.
Sci Rep ; 11(1): 700, 2021 01 12.
Article in English | MEDLINE | ID: mdl-33436829

ABSTRACT

Endovascular management of small visceral artery aneurysms is an established treatment with satisfactory outcomes. However, when size exceeds 5 cm visceral aneurysms are considered as "giant" (giant visceral artery aneurysms or GVAAs) and management is significantly more complex. Between August 2007 and June 2019 eleven cases of GVAAs that were endovascularly treated were retrospectively reviewed and included in this single center study. Mean size was 80 mm (± 26.3 mm) x 46 mm (+ \-11.8 mm). Nine of the lesions were true aneurysms, and two were pseudoaneurysms. In 8 patients, the lesion was causing compression symptoms in the surrounding organs, one patient developed a contained rupture while 2 patients were completely asymptomatic. However, all patients were hemodynamically stable at the time of treatment. Technical success was defined as immediate complete exclusion of the aneurysmal sac, and clinical success as complete relief from clinical symptoms. Follow-up was performed with CT angiography, ultrasound and clinical examination. Mean follow-up was 45 months (range 6-84). Technical and clinical success were both 91%. Complications were one lack of control of contained rupture that was subsequently operated, one case of self-limiting non-target spleen embolization and one case of splenic abscess. Three patients died, one due to the contained rupture 15 days after procedure, the other two for other causes and occurred during the long-term follow-up. This series suggests that endovascular treatment of giant visceral artery aneurysms and pseudoaneuryms is a valid minimally invasive solution with very satisfactory immediate and long-term outcomes unless the aneurysm is already ruptured. A variety of endovascular tools may be required for successful treatment.


Subject(s)
Aneurysm/therapy , Embolization, Therapeutic/methods , Endovascular Procedures/methods , Splenic Artery , Viscera/blood supply , Adult , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
6.
J Vasc Access ; 21(1): 79-85, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31232151

ABSTRACT

PURPOSE: To retrospectively assess the efficacy and safety of FemoSeal® vascular closure device to achieve hemostasis following antegrade common femoral artery puncture after lower limb revascularization using vascular sheaths from 5 to 8 Fr. METHODS: We reviewed the hemostatic outcome achieved with FemoSeal in 103 consecutive patients (mean age: 69 ± 8 years, 71 males) that undergone to 111 antegrade common femoral artery accesses for percutaneous lower limbs revascularization using 5- to 8-Fr vascular sheaths. We used FemoSeal in an unselected population, without exclusion criteria. The primary outcome was the technical success, meant as achieving complete hemostasis without immediate complications. RESULTS: Hemostasis was achieved in all 111 puncture sites (100% technical success). We observed eight (7%) puncture site minor complications (hematomas), none of which affecting the patients' outcome or requiring further therapies or increasing the hospital stay. There were no statistically significant differences between the variables potentially related to the occurrence of complications (age, international normalized ratio, platelet count, partial thromboplastin time ratio, body mass index, and common femoral arteries calcification grade) in patients with and without complications. Complications group mean body mass index was 26.4 ± 2.8 kg/m2 versus non-complications group 26.6 ± 4.4 kg/m2, p = 0.92. Mean international normalized ratio and partial thromboplastin time ratio were 1.05 ± 0.01 and 1.05 ± 0.14 versus 1.13 ± 0.2 (p = 0.39) and 1.12 ± 0.23 (p = 0.53), respectively. Common femoral arteries calcification grade was the same (mean: 1, p = 1). Platelet count was 202 × 103/mL ± 66.7 versus 226 × 103/mL ± 91.2, p = 0.55. Mean age was 72.3 ± 10 years versus 72.8 ± 8 years, p = 0.86. CONCLUSION: The low rate (7%) and grading of the adverse events, combined with the high technical success rate (100%), in an unselected group of patients treated in daily routine, suggest high safety and efficacy of FemoSeal vascular closure device in antegrade common femoral artery puncture site hemostasis when using vascular sheaths ranging from 5 to 8 Fr. Therefore, FemoSeal could be considered as a first-line hemostasis strategy in such cases.


Subject(s)
Catheterization, Peripheral , Femoral Artery , Hemorrhage/prevention & control , Hemostatic Techniques/instrumentation , Vascular Closure Devices , Aged , Catheterization, Peripheral/adverse effects , Equipment Design , Female , Hemorrhage/etiology , Hemostatic Techniques/adverse effects , Humans , Male , Middle Aged , Punctures , Retrospective Studies , Treatment Outcome
7.
Insights Imaging ; 10(1): 91, 2019 Sep 23.
Article in English | MEDLINE | ID: mdl-31549250

ABSTRACT

The presence of endoleaks remains one of the main drawbacks of endovascular repair of abdominal aortic aneurysms leading to the increase of the size of the aneurysmal sac and in most of the cases to repeated interventions. A variety of devices and percutaneous techniques have been developed so far to prevent and treat this phenomenon, including sealing of the aneurysmal sac, endovascular embolisation, and direct sac puncture. The aim of this review is to analyse the indications, the effectiveness, and the future perspectives for the prevention and treatment of endoleaks after endovascular repair of abdominal aortic aneurysms.

8.
BMJ Support Palliat Care ; 9(1): e2, 2019 Mar.
Article in English | MEDLINE | ID: mdl-28424195

ABSTRACT

The combination of percutaneous vertebroplasty with radiofrequency ablation (verteblation) has not shown to be an effective measure of pain management in patients with metastatic lesions of the spine. The use of this novel technique has not been previously described in metastatic disease from thyroid cancer. We would like to report our experience after treating a patient affected by a thyroid carcinoma and an osteolytic spine metastasis. The patient suffered from life-limiting pain and was successfully treated with a combination of vertebroplasty and radiofrequency ablation. This case shows that the indications of verteblation may be expanded in the palliative treatment of metastatic disease from thyroid carcinoma.


Subject(s)
Catheter Ablation/methods , Low Back Pain/surgery , Palliative Care/methods , Spinal Neoplasms/surgery , Thyroid Neoplasms , Vertebroplasty/methods , Combined Modality Therapy , Female , Humans , Middle Aged , Pain Management , Spinal Neoplasms/secondary , Treatment Outcome
10.
Cardiovasc Intervent Radiol ; 41(9): 1340-1345, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29748820

ABSTRACT

PURPOSE: The safety of liquid embolics over the conventional coils for the treatment of non-variceal upper gastrointestinal bleeding (UGIB) approach is still unclear. Purpose of this study is to assess the safety of ethylene-vinyl alcohol copolymer (EVOH 6%) over coils in the treatment of UGIB. MATERIALS AND METHODS: All the upper gastrointestinal tract embolization procedures performed in a single center in a 6-year period were reviewed. Patients embolised with coils (Group A) versus those embolised with EVOH 6% (Group B) were compared. Technical/clinical success, bleeding recurrence, complication and mortality rates were analyzed. RESULTS: A total 71 patients were included in the study (41 Group A and 30 Group B). Coagulopathy was present in 21% of Group A and 46% of Group B patients (p < 0.05). Technical and clinical success was 97.6 and 92.7% for Group A, and 100 and 93.3% for Group B respectively, (p > 0.05). Ten patients (17% Group A; 10% Group B) re-bled within the first 36 h and all of them were re-treated successfully with a second embolization. In Group A one major complication (bowel ischemia) occurred. No complication occurred in Group B. The survival rate in the first 30 days was 90.3% for group A and 90% for group B (p > 0.05). CONCLUSION: This study demonstrated EVOH 6% appears to be as safe and effective as coils in the treatment of non-variceal UGIB.


Subject(s)
Embolization, Therapeutic/methods , Gastrointestinal Hemorrhage/therapy , Polyvinyls/therapeutic use , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Polyvinyls/adverse effects , Recurrence , Retrospective Studies , Survival Rate , Treatment Outcome , Upper Gastrointestinal Tract
11.
Interv Med Appl Sci ; 10(4): 213-215, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30792916

ABSTRACT

A rare postoperative complication of aortic root replacement is pseudoaneurysm formation. Surgical repair may be rather challenging particularly in patients who are elder and with significant comorbidities. Endovascular approach may also be technically demanding, given the high blood velocity and the anatomical challenges of the area of the aortic root and the ascending aorta. We would like to describe a case of an 85-year-old patient with history of prosthetic graft aortic root replacement who had been developed a 7-cm pseudoaneurysm with sternotomy diastasis and extension in the subcutaneous tissue, 7 years after the initial operation. Given the comorbidities, open repair was not considered a valid option and successful endovascular repair with the use of a ventricular septal occluder plug followed. One-year follow-up confirmed satisfactory exclusion of the pseudoaneurysm with no migration of the endovascular device and no other complication. This is one of the rare cases on endovascular repair of an ascending aorta postoperative pseudoaneurysm.

12.
Cir Esp ; 95(5): 283-292, 2017 May.
Article in English, Spanish | MEDLINE | ID: mdl-28583724

ABSTRACT

INTRODUCTION: The aim of this study is to analyze the safety and efficacy of stent-graft endovascular treatment for visceral artery aneurysms and pseudoaneurysms. METHODS: Multicentric retrospective series of patients with visceral aneurysms and pseudoaneurysms treated by means of stent graft. The following variables were analyzed: Age, sex, type of lesion (aneurysms/pseudoaneurysms), localization, rate of success, intraprocedural and long term complication rate (SIR classification). Follow-up was performed under clinical and radiological assessment. RESULTS: Twenty-five patients (16 men), with a mean age of 59 (range 27-79), were treated. The indication was aneurysm in 19 patients and pseudoaneurysms in 6. The localizations were: splenic artery (12), hepatic artery (5), renal artery (4), celiac trunk (3) and gastroduodenal artery (1). Successful treatment rate was 96% (24/25 patients). Intraprocedural complication rate was 12% (4% major; 8% minor). Complete occlusion was demonstrated during follow up (mean 33 months, range 6-72) in the 24 patients with technical success. Two stent migrations (2/24; 8%) and 4stent thrombosis (4/24; 16%) were detected. Mortality rate was 0%. CONCLUSION: In our study, stent-graft endovascular treatment of visceral aneurysmns and pseudoaneurysms has demonstrated to be safe and is effective in the long-term in both elective and emergent cases, with a high rate of successful treatment and a low complication rate.


Subject(s)
Aneurysm/surgery , Endovascular Procedures , Stents , Adult , Aged , Aneurysm, False/surgery , Female , Humans , Male , Middle Aged , Retrospective Studies , Time Factors , Treatment Outcome , Viscera/blood supply
13.
Cir. Esp. (Ed. impr.) ; 95(5): 283-292, mayo 2017. tab, ilus
Article in Spanish | IBECS | ID: ibc-163968

ABSTRACT

Introducción: El objetivo de este estudio fue analizar la eficacia y la seguridad del tratamiento de los aneurismas y pseudoaneurismas de arterias viscerales mediante la utilización de stenstents recubiertos. Métodos: Serie retrospectiva multicéntrica de pacientes intervenidos por aneurisma o pseudoaneurisma mediante stents recubiertos. Las variables estudiadas fueron: edad, sexo, tipo de lesión (aneurisma/pseudoaneurisma), localización, tasa de éxito terapéutico, tasa de complicaciones durante el procedimiento (según la clasificación SIR) y en el seguimiento. El seguimiento fue realizado mediante evaluación clínica y radiológica. Resultados: Se trató a 25 pacientes (16 hombres) con una edad media de 59 años (rango 27-79). Diecinueve pacientes presentaban aneurismas y los restantes 6, pseudoaneurismas; la localización principal fue la arteria esplénica (12) seguida por las arterias hepática (5), renal (4), tronco celiaco (3) y gastroduodenal (1). La tasa de éxito fue del 96% (24/25 pacientes). Las complicaciones intraprocedimiento fueron del 12% (4% mayores; 8% menores). El tiempo medio de seguimiento fue de 33 meses (rango 6-72 meses) en los 24 pacientes con éxito técnico, con oclusión completa del aneurisma en todos los casos. En el seguimiento se observaron 2 casos de migración (2/24; 8%) y 4de trombosis del dispositivo (4/24; 16%); en ninguno de estos pacientes se produjo daño isquémico del órgano. La mortalidad debida al procedimiento fue del 0%. Conclusiones: En nuestro estudio, el tratamiento endovascular de los aneurismas y pseudoaneurismas viscerales mediante stents recubiertos demuestra ser seguro y eficaz a largo plazo, tanto de forma electiva como en urgencia, con una alta tasa de éxito terapéutico y una baja tasa de complicaciones (AU)


Introduction: The aim of this study is to analyze the safety and efficacy of stent-graft endovascular treatment for visceral artery aneurysms and pseudoaneurysms. Methods: Multicentric retrospective series of patients with visceral aneurysms and pseudoaneurysms treated by means of stent graft. The following variables were analyzed: Age, sex, type of lesion (aneurysms/pseudoaneurysms), localization, rate of success, intraprocedural and long term complication rate (SIR classification). Follow-up was performed under clinical and radiological assessment. Results: Twenty-five patients (16 men), with a mean age of 59 (range 27-79), were treated. The indication was aneurysm in 19 patients and pseudoaneurysms in 6. The localizations were: splenic artery (12), hepatic artery (5), renal artery (4), celiac trunk (3) and gastroduodenal artery (1). Successful treatment rate was 96% (24/25 patients). Intraprocedural complication rate was 12% (4% major; 8% minor). Complete occlusion was demonstrated during follow up (mean 33 months, range 6-72) in the 24 patients with technical success. Two stent migrations (2/24; 8%) and 4stent thrombosis (4/24; 16%) were detected. Mortality rate was 0%. Conclusion: In our study, stent-graft endovascular treatment of visceral aneurysmns and pseudoaneurysms has demonstrated to be safe and is effective in the long-term in both elective and emergent cases, with a high rate of successful treatment and a low complication rate (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Endovascular Procedures/methods , Aneurysm, False/surgery , Aneurysm/surgery , Embolization, Therapeutic/methods , Drug-Eluting Stents , Retrospective Studies
14.
Ann Med ; 49(4): 283-290, 2017 06.
Article in English | MEDLINE | ID: mdl-27690642

ABSTRACT

BACKGROUND: Atherosclerosis is a multifactorial disease characterized by an immune-inflammatory remodeling of the arterial wall. Treg and Th17 subpopulations are detectable inside atherosclerotic plaque; however, their behavior in symptomatic carotid artery stenosis (CAS) is not fully elucidated. The aim of this study was to evaluate Th17 and Treg subsets and their ratio in patients affected by symptomatic and asymptomatic CAS. METHODS: 14 patients with symptomatic CAS (CAS-S group), 41 patients with asymptomatic CAS (CAS-A group), 32 subjects with traditional cardiovascular risk factors (RF group), and 10 healthy subjects (HS group) were enrolled. Th17 and Treg frequency was determined by flow cytometry and by histology and immunohistochemistry. Interleukin (IL)-10, IL-17, and metalloproteinase (MMP)-12 levels were measured by ELISA. RESULTS: Th17 were significantly increased in CAS-A versus RF and versus HS. Tregs were significantly increased in CAS-S versus CAS-A. Tregs/Th17 ratio was significantly reduced in CAS-A versus RF and versus HS, whereas it was significantly increased in CAS-S versus CAS-A. CONCLUSIONS: The results of this study suggest that Th17 are related to the late stages of CAS but not to plaque instability. Moreover, Treg expansion seems to represent a specific cellular pattern displayed by patients with symptomatic CAS and associated with brain injury. KEY MESSAGES Tregs expansion seems to represent a specific cellular pattern displayed by patients with symptomatic CAS and associated with CD4+ effector depletion and brain ischemic injury. Th17 lymphocytes are related to the late stages of CAS but not to plaque instability.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , Carotid Stenosis/immunology , Interleukin-2 Receptor alpha Subunit/metabolism , T-Lymphocytes, Regulatory/metabolism , Th17 Cells/metabolism , Aged , Aged, 80 and over , Carotid Stenosis/metabolism , Female , Humans , Interleukin-10/metabolism , Interleukin-17/metabolism , Male , Matrix Metalloproteinase 12/metabolism , Middle Aged
15.
Minerva Cardioangiol ; 65(2): 179-183, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27808484

ABSTRACT

Transradial access for percutaneous coronary and non-coronary intervention has gained worldwide acceptance. This approach has demonstrated less bleeding and vascular events with a reduced in-hospital stay, and an improvement in clinical outcomes when compared to the traditional transfemoral approach. However, this strategy may occasionally lead to severe catheter kinking and further manipulation may be required to unravel the catheter and avoid complication. Purpose of this review article is to present the current knowledge and evidence in preventing and potentially resolving issues related to radial access catheter knots.


Subject(s)
Cardiac Catheterization/adverse effects , Catheters/adverse effects , Percutaneous Coronary Intervention/adverse effects , Percutaneous Coronary Intervention/methods , Postoperative Complications/prevention & control , Humans
16.
Minerva Cardioangiol ; 65(1): 52-60, 2017 02.
Article in English | MEDLINE | ID: mdl-27654819

ABSTRACT

Percutaneous embolization was introduced in the mid-'70s and is now an established therapeutic procedure in current medical practice. With the use of improved imaging techniques, smaller profile catheters and new tools, embolization boundaries are significantly expanded in the last decades. Detachable coils were initially introduced in neuroradiology and are now part of the everyday peripheral embolization armamentarium. Purpose of this review article is to present an overview of the expanded possibilities that this novel material is offering in the field of peripheral embolization procedures.


Subject(s)
Embolization, Therapeutic/instrumentation , Embolization, Therapeutic/methods , Angiography , Embolization, Therapeutic/trends , Endovascular Procedures/instrumentation , Endovascular Procedures/methods , Endovascular Procedures/trends , Humans
17.
Eur Radiol ; 26(6): 1620-30, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26373762

ABSTRACT

OBJECTIVES: To retrospectively evaluate safety and efficacy of pelvic artery embolisation (PAE) in post-partum haemorrhage (PPH) in abnormal placental implantation (API) deliveries. METHODS: From January 2009 to November 2013, 12 patients with API and intractable intraoperative PPH underwent PAE after caesarean delivery to control a haemorrhage (in four of these cases after hysterectomy). Arterial access was obtained prior to the delivery; PAE was performed in the obstetrics operating room by an interventional radiologist that was present with an interventional radiology (IR) team during the delivery. RESULTS: PAE was successful in preventing bleeding and avoid hysterectomy in four cases (group A). Uterine atony and disseminated intravascular coagulation caused failure of PAE requiring hysterectomy in four patients (group B). PAE prevented bleeding post-hysterectomy in the remaining four cases (group C). Technical success (cessation of contrast extravasation on angiography or occlusion of the selected artery) was 100 %. Maternal and foetal mortality and morbidity were 0 %. CONCLUSIONS: PAE is a minimal invasive technique that may help to prevent hysterectomy and control PPH in API pregnancies without complications. Embolisation should be performed on an emergency basis. For such cases, an IR team on standby in the obstetrics theatre may be useful to prevent hysterectomy, blood loss and limit morbidity. KEY POINTS: • Endovascular treatment is a validated technique in post-partum haemorrhage. • Abnormal placental implantation is a risk factor for post-partum haemorrhage. • We propose an interventional radiologist standby in the delivery room.


Subject(s)
Embolization, Therapeutic/methods , Endovascular Procedures/methods , Placenta Accreta/therapy , Placenta Previa/therapy , Postpartum Hemorrhage/therapy , Adult , Cesarean Section , Female , Humans , Pregnancy , Retrospective Studies , Treatment Outcome , Uterine Artery
19.
Cardiovasc Intervent Radiol ; 38(1): 13-24, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25366087

ABSTRACT

Within the group of Gastro-Entero-Pancreatic Neuroendocrine tumours (GEP-NETs), several heterogeneous malignancies are included with a variety of clinical manifestations and imaging characteristics. Often these cases are inoperable and minimal invasive treatment offered by image-guided procedures appears to be the only option. Interventional radiology offers a valid solution in the management of primary and metastatic GEP-NETs. The purpose of this review article is to describe the current status of the role of Interventional Radiology in the management of GEP-NETs.


Subject(s)
Diagnostic Imaging , Intestinal Neoplasms/diagnosis , Intestinal Neoplasms/therapy , Neuroendocrine Tumors/diagnosis , Neuroendocrine Tumors/therapy , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/therapy , Radiology, Interventional , Stomach Neoplasms/diagnosis , Stomach Neoplasms/therapy , Catheter Ablation , Embolization, Therapeutic , Humans
20.
Scand J Infect Dis ; 46(10): 727-31, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25134653

ABSTRACT

Hepatitis E virus (HEV) is the most important causative agent of acute hepatitis in developing countries. The disease is usually characterized by a self-limiting, benign course. However, when particular conditions coexist (pregnancy, old age, pre-existing liver disease) it may run an unfavourable course. To date, 4 HEV genotypes have been described. Historically, in the Western world, HEV infection was considered a travel-related disease, however in the last 2 decades a great number of non-travel-related autochthonous cases have been described, more often related to genotype 3 or 4 and in the context of zoonosis. We report the case of an elderly Italian man with an acute fulminant HEV infection genotype 3e that developed in the context of pre-existing liver disease; this is the first case of an unfavourable outcome associated with subgenotype 3e. The potential pathogenicity of this subgenotype together with the influence of host-related risk factors are discussed.


Subject(s)
Hepatitis E virus/classification , Hepatitis E virus/isolation & purification , Hepatitis E/diagnosis , Hepatitis E/virology , RNA, Viral/genetics , Aged , Cluster Analysis , Genotype , Hepatitis E virus/genetics , Humans , Italy , Male , Phylogeny , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...